XJSE
DCP
Market cap1.76bUSD
Dec 04, Last price
3,470.00ZAR
1D
0.55%
1Q
7.30%
Jan 2017
54.91%
IPO
66.03%
Name
Dis-Chem Pharmacies Ltd
Chart & Performance
P/E
25.30
P/S
0.76
EPS
1.37
Div Yield, %
0.65%
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
10.31%
Revenues
39.17b
+7.96%
Net income
1.18b
+19.84%
CFO
905m
-52.14%
Dividend
Jun 19, 202422.493 ZAR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments, Retail and Wholesale. It owns and operates a chain of retail stores that offers a range of products, including dispensary, personal care and beauty, healthcare and nutrition, baby care products, and other products, as well as offers ancillary services that include healthcare clinics, and hair and beauty salons. The company also manages an online platform that provides click & collect services. In addition, it is involved in the wholesale of pharmaceutical, health, and front shop products; pharma-logistic services; and provision of customer loyalty programs. The company operates 289 stores across all nine provinces in South Africa, four in Namibia, and two in Botswana. The company was founded in 1978 and is headquartered in Midrand, South Africa.
Valuation
Title ZAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑02 | 2024‑02 | 2023‑02 | 2022‑02 | 2021‑02 | 2020‑02 | 2019‑02 | 2018‑02 | 2017‑02 | 2016‑02 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||